Intra-abdominal infections are common in young infants and lead to significant morbidity and mortality. Meropenem is a broad-spectrum antimicrobial with excellent activity against pathogens associated with intra-abdominal infections. The purpose of this study was to determine the safety and effectiveness of meropenem in young infants with suspected or complicated intra-abdominal infections.
Original Source [2]
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/safety-and-effectiveness-meropenem-infants-suspected-or-complicated-intra-abdominal
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491861/pdf/cis758.pdf
[3] http://admin.indiaenvironmentportal.org.in/category/author/michael-cohen-wolkowiez
[4] http://admin.indiaenvironmentportal.org.in/category/author/brenda-poindexter
[5] http://admin.indiaenvironmentportal.org.in/category/author/margarita-bidegain-et-al
[6] http://admin.indiaenvironmentportal.org.in/category/journal/clinical-infectious-diseases
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/antibiotic
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/micro-organisms
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-states-america-us